ABSTRACT This study aimed to investigate the effect of mannose-binding lectin (MBL) on infections with Escherichia coli in chickens. Initially, the basic levels of MBL in 4 different lines of layer chickens, namely ISA Brown, Lohmann Selected Leghorn, Lohmann Braun, and Hellevad, were investigated. This investigation revealed a 2-to 3-fold difference in the basic levels of MBL in serum between some of these commercial lines. Furthermore, the ontogeny of the basic level of MBL in serum of an experimental chicken line was investigated. The level of MBL was very stabile for long periods, with an elevation at 5 to 7 wk of age. Another elevation in MBL level started around 18 to 19 wk of age and stayed elevated at least until 38 wk of age. In this study, it was hypothesized that chickens with high levels of MBL (H-type) may be less prone to disease caused by E. coli infection than chickens with low levels of MBL (L-type) after attempts were made to immunosuppress the chickens by immunization with a live attenuated infectious bursal disease virus (IBDV) vaccine strain. The H-type and L-type chickens were divided into 4 groups receiving either no treatment (I−E−), E. coli alone (I−E+), IBDV alone (I+E−), or IBDV and E. coli (I+E+). Body weight gain was depressed by IBDV immunization as well as E. coli inoculation. The depression of BW gain was significantly larger in L-type chickens compared with H-type chickens. The antibody response to E. coli was significantly depressed by IBDV vaccination and antibody titers to E. coli were elevated by experimental E. coli inoculation, but only in the group not given IBDV (I−E− vs. I−E+). On d 28, T-cell responses in L-type chickens showed a lower percentage of proliferating CD4+ and CD8+ T cells compared with the H-type, regardless of treatment. In conclusion, immune reactions toward infections with E. coli differed between chickens having different basal serum MBL levels, and as such, MBL may be of importance for future selection of more robust chickens for outdoor or organic farming.
INTRODUCTION
Infections with Escherichia coli are responsible for a broad range of diseases in poultry production. Colibacillosis is probably one of the most costly diseases in the commercial raising of chickens. The breeding material of laying hens has primarily been selected for a high egg production in systems with individual batteries. Selection in systems with high biosecurity will often be at the expense of genetically determined disease resistance because manure-determined infections under these conditions are almost completely eliminated. Free-range production requires that the chickens are able to handle a broad range of pathogens not seen in the pathogenlow environments that most commercial chicken lines have been reared under.
The glycoprotein mannose-binding lectin (MBL) is a carbohydrate-binding protein that selectively recognizes several structural oligosaccharide components on the surface of microorganisms in the presence of calcium (Turner, 1996) . When MBL has bound to a microorganism, it promotes killing of the microorganism either by acting directly as an opsonin or via the MBL-associated serine proteases (MASP-1 and MASP-2) by activating the lectin complement pathway. Thereby, MBL plays a major role in the first-line innate immune defense against bacteria, viruses, and parasites. Although MBL is an important part of the innate immune defense, the serum levels of MBL in commercial chicken lines are unknown.
Similar to mammals, chickens produce MBL in the hepatocytes, secrete it into the blood, and upregulate the production during acute stages of virus infections (Laursen and Nielsen, 2000; Juul-Madsen et al., 2003) . Mannose-binding lectin is regarded as a minor acute phase protein in that it is elevated only 2-to 3-fold in virus-infected chickens compared with uninfected controls (Nielsen et al., 1999; Juul-Madsen et al., 2002 , 2003 . However, Juul-Madsen et al. (2007) showed that propagation of infectious bronchitis virus (IBV) in trachea was impaired in chickens with a high basal serum level of MBL compared with chickens with a low serum level of MBL. This demonstrates that MBL plays an important role in the immunological defense against pathogens. After infecting 2 Vietnamese breeds experimentally with Pasteurella multocida, chickens developing systemic infections had a significantly lower mean MBL concentration than the rest of the chickens (Schou et al., 2008) . Furthermore, disease resistance in humans and pigs has been shown to be highly associated with the level of MBL (Summerfield et al., 1997; Lillie et al., 2007) .
Because infection with infectious bursal disease virus (IBDV) causes suppression of the humoral immune defense, and also to some degree affects the cellular immune defense, parts of the innate immune defense become of much greater importance in controlling infections. In the present experiment, chickens were subjected to a live attenuated IBDV vaccine because, according to Hair-Bejo et al. (2004) , an intermediate strain of live attenuated IBD vaccine is able to cause suppression of the adaptive immune defense, especially when given around 2 wk of age. The vaccination was followed by a challenge consisting of inoculation with experimental E. coli. This combination gave the opportunity to evaluate the immune response to potentially pathogenic bacteria strains. The experiment was performed in chicken lines selected for high and low basal levels of MBL to evaluate the importance of MBL in interaction with E. coli.
MATERIALS AND METHODS

Part 1: Study on the Basal Serum MBL Level in 4 Different Commercial Chicken Lines
To determine the basal levels of MBL in chickens of different commercial layer lines, a study was performed with chickens of the ISA Brown (ISA), Lohmann Selected Leghorn (LSL), Lohmann Braun (LB), and Hellevad (HE) types. Two flocks of ISA, LSL, and LB were used for the study, and at each time point, 20 chickens were randomly selected for blood sampling. In the study, ISA flock 1, ISA flock 2, and LSL flock 1 were tested at 16, 25, 35, 45 , and 55 wk of age. In addition, LB flock 1 was tested at 17, 25, 36, 47, and 56 wk of age and LB flock 2 and LSL flock 2 were tested at 3, 6, 9, 14, and 16 wk of age. Twenty-five HE were bled at
Part 2: Study on the Ontogenetic Development of Serum MBL in an Experimental Chicken Line
The ontogenetic development in basal serum levels of MBL in 8 chickens of a single line was determined in line 22 (L22) chickens (Cornell line K; Cole and Hutt, 1973) . Mannose-binding lectin levels were measured regularly from wk 3 to 42.
Part 3: Assessment of Serum MBL Levels After Inoculation with Different Concentrations of E. coli in Chickens
Chickens. The experiment was performed with layer chickens of the HE type. For the first 6 wk, the chickens were commercially raised according to normal Danish standards. At 6 wk of age, the chickens were transferred to positive-pressure isolation chambers at the Research Centre Foulum (University of Aarhus, Denmark) and individually marked. Water and commercial chicken feed were supplied ad libitum. The lighting period was 12 h daily from 0700 to 1900 h, and the chickens were subjected to a constant temperature of 21°C.
Infections and Design. The experimental infections were performed in 2 independent, identical trials, each including 44 chickens. The chickens in each experiment were allocated at random to 4 groups of 11 birds and placed in 4 isolation chambers. The experimental groups were control (mock inoculated with sterile NaCl 0.9%), 10 6 , 10 8 , and 10 10 according to the inoculation concentration (cfu) of E. coli in NaCl 0.9%. All chickens were inoculated orally and nasally with 1 mL of inoculum at d 0, 1, and 2. The experiment was terminated after 8 d.
Serum and Tissue Samples. Serum samples were collected from 5 chickens in each group at d 0, 2, 4, and 6. All samples were taken between 0800 and 1000 h. A further 2 chickens from each group were killed at d 1, 2, and 3 postinoculation, and the left lung was aseptically removed to be tested for the presence of E. coli.
Part 4: Effect of Serum MBL Levels on Susceptibility to E. coli After Immune Suppression
Chickens. The experiment was performed with chickens from a line selected for a high (H-line) or low (L-line) basal level of MBL for 7 generations. The chickens comprised 67.5% UM-19 and 33.5% White Cornish , and the parents had not been vaccinated against IBDV. The chickens were raised in flocks, wing-banded, and transferred to positive-pres-sure isolation chambers at 2 1/2 wk of age. Water and commercial chicken feed were supplied ad libitum. The lighting period was 12 h daily, and the chickens were subjected to a temperature of 21°C in the isolation chambers.
Infections and Design. The experiment lasted for 28 d and the experimental infections were performed in 2 independent, identical trials, each including 72 chickens of the H-line and 72 chickens of the L-line. The chickens were allocated to 2 × 4 groups consisting of 9 birds of each line and placed in 8 isolation chambers (2 isolation chambers for each experimental group). The experimental groups are given in Table 1 . On d 0, all chickens were inoculated orally with either live attenuated vaccine against IBD (Nobilis Gumboro D78 Vet, Intervet, Boxmeer, the Netherlands) or water. The vaccine was dissolved in sterilized water and given as 0.5 mL containing 10 4 tissue culture infectious dose 50 per chicken. On d 7, 8, and 9, all chickens were inoculated orally and nasally either with 0.5 mL of E. coli inoculum (10 8 cfu) or with 0.5 mL of sterile NaCl 0.9%. Serum and Tissue Samples. Serum samples were collected from 4 chickens from each line in each isolation chamber at d 7, 9, 10, 11, 14, 21, and 28 (a total of 64 samples per day). All samples were taken between 0800 and 1000 h. On d 7, 9, 10, 11, and 14, one chicken from each line in each isolation chamber was killed. Bursa of Fabricius was removed and weighed. Furthermore, on d 7, 9, and 10, the left lung was aseptically removed and tested for the presence of E. coli.
General Methods
Bacterial Culture for Inoculation. A mixture of 3 E. coli strains, O2, O11, and O78, was used for inoculation. The E. coli strains are isolated field strains known to cause colibacillosis in chicken flocks. Each of the E. coli strains was cultured for 4 to 5 h at 37°C in Bacto Veal Infusion Broth (Becton Dickinson, Le Pont de Claix, France), centrifuged at 17,000 × g at 4°C for 15 min and resuspended in 0.9% NaCl. A mixture from each of the 3 isotypes of E. coli of 10 10 cfu/mL was prepared. The mixture was then made in 3 dilutions for the experimental infections in part 3, namely 10 6 , 10 8 , and 10 10 cfu/mL, and in a dilution of 2 × 10 8 cfu/mL for the experimental infections in part 4.
E. coli in Lung Tissue. Lung tissue was placed in sterile NaCl 0.9%, and the lungs were shredded with scissors. The tissue was mixed for 2 min in sterile Steriblend bags (Bibby Sterilin, Staffordshire, UK) on a BagMixer (Interscience, Saint Nom La Bretèche, France) before it was tested in culture on blood agar and MacConkey-Agar (Merck, Darmstadt, Germany) for the presence of E. coli.
ELISA Measurements of Serum MBL. Serum MBL was determined in a sandwich ELISA as described by Norup and Juul-Madsen (2007) . Mouse anti-MBL (HYB 182-01, Statens Serum Institut, Copenhagen, Denmark) was used as capture antibody and biotin conjugated HYB 182-01 (Statens Serum Institut). A dilution series of a normal chicken serum (stored at −20°C in aliquots) was used as standard, and selected serum samples were used as high-and low-level controls.
ELISA Measurements of Serum IBDV Antibody Titers. The ProFLOK IBD ELISA Test Kit (Synbiotics Corporation, San Diego, CA; Juul-Madsen et al., 2006) was used to measure serum IgG antibody titers against IBDV. The ELISA assay was performed according to the kit manual. Briefly, 96-well microtiter plates coated with IBDV antigen were incubated for 30 min at room temperature (RT) with 100-μL serum samples and positive and negative kit controls in a 1:100 dilution, followed by incubation for 30 min at RT with a horseradish peroxidase (HRP) conjugated affinity purified antibody from a pool of serum from goats immunized with chicken IgG (H+L). 2,2'-Azinodi 3-ethyl benzthiazoline sulfonic acid was used as chromogen and 5% SDS as stop solution. The result was monitored as optical density at 405 nm and the antibody titer was calculated from the following equation format: SP = (sample absorbance) − (average normal control absorbance)/corrected positive control absorbance). Titers exceeding 1,000 were considered positive.
ELISA Measurements of Serum E. coli Antibody Titers. Microtiter wells (Maxisorp, Nunc, Roskilde, Denmark) were coated with 100 μL of sonicated E. coli (mixture of the 3 strains, O2, O11, and O78) suspended in a carbonate buffer of 15 mM Na 2 CO 3 , 35 mM NaHCO 3 , pH 9.6 (a stock of sonicated E. coli with an OD 600/1cm of 1.63 diluted 1:30). After incubation overnight at 4°C, residual protein-binding sites were blocked by 200 μL of PBS containing 1% (wt/vol) BSA in 130 mM NaCl, 9.6 mM Na 2 HPO 4 •2H 2 O, 2.2 mM KH 2 PO 4 , pH 7.4 (PBS) for at least 1 h at RT. After washing in 200 μL of PBS containing BSA 0.05% (wt/vol; PBS-BSA), 100 μL of diluted serum in PBS-BSA was added to the wells. Wells receiving only buffer were used as negative controls, and as standard, a dilution series of 
a serum, selected on the basis of a high optical density, was used (units are given arbitrarily in proportion to this serum). All dilutions were added in duplicate. After incubation for 1 1/2 h at RT and washing in PBS-BSA, the wells received 10 ng of HRP conjugated goat anti-chicken IgG (AA129P, Serotec, Oxford, UK) in 100 μL of PBS-BSA. Upon further incubation for 1 h and washing using PBS-BSA, the presence of HRP was determined by adding 100 μL of substrate solution (<0.05% wt/wt 3,3′,5,5′-tetramethylbenzidine). Color development was stopped with a 1-M solution of H 2 SO 4 and was determined by reading the absorbance at 450 nm with absorbance at 650 nm as a reference.
To be certain that all antibodies bound were specific for E. coli, serum samples were prepared in a nonprecipitated and a precipitated version. Serum was precipitated with a suspension of sonicated E. coli (0.7 μL of E. coli stock/μL of serum), incubated for 1 h at RT, followed by centrifugation (17,000 × g for 15 min, 20°C). All titers were calculated from the standard curve, and the actual antibody titer for each sample was thereafter calculated as the difference between the nonprecipitated and the precipitated titer value. Intra-and interassay variations were 8.5 and 12.1, respectively, for the high E. coli antibody serum control and 6.3 and 9.0, respectively, for the low E.coli antibody serum control.
T-Cell Stimulation Assay. Peripheral blood mononuclear cells were obtained from heparinized blood by separation on a Ficoll-Paque Plus (Amersham Biosciences, Uppsala, Sweden) gradient. A total of 2 × 10 7 cells were resuspended in 2 mL of PBS containing 0.1% fetal bovine serum (FBS, Gibco, Invitrogen Corp., Carlsbad, CA) and carboxyfluorescein diacetate succinimidyl ester (Cell Trace CFSE Cell Proliferation Kit, Molecular Probes, Carlsbad, CA; Quah et al., 2007) according to the manufacturer's specifications; CFSE was used in a 0.5 μM concentration. After incubation for 10 min at 37°C, an equal amount of RPMI-1640 containing streptomycin, penicillin, and l-glutamine (RPMI, Cambrex, Rockland, ME) supplemented with 10% FBS was added to stop the reaction. Subsequently, cells were washed twice with RPMI by centrifugation for 5 min at 296 × g at 20°C. After washing, the cells were resuspended in RPMI at a final concentration of 1 × 10 7 cells/mL. Cells were cultivated in RPMI-1640 with 10% FBS in the presence of ConA (Sigma-Aldrich, St. Louis, MO) at a concentration of 10 or 20 μg/mL for 3 d (5% CO 2 , 40°C). Cells cultivated in RPMI with 10% FBS only were used as negative controls.
Flow Cytometry. For flow cytometric analysis, cells cultured in the presence of 10 μg/mL of ConA were stained with CD4-RPE antibody (clone: CT-4, Southern Biotech, Birmingham, AL), and cells cultured in the presence of 20 μg/mL of ConA were stained with CD8β-RPE antibody (clone: EP42, Southern Biotech). Cells were stained for 25 min at RT, washed twice in fluorescence-activated cell sorting (FACS) buffer (PBS with 0.05% horse serum, 0.1% BSA, and 0.2% azide), and resuspended in FACS buffer to a final concentration of 10 6 cells/mL. Flow cytometric analysis was performed on a FACS-Canto (BD Biosciences, San Jose, CA) flow cytometer using the FACS-Diva software. Random samples were tested by propidium iodide staining to evaluate the amount of dead cells.
Statistical Analysis
Part 3. The MBL acute phase response as a result of inoculated doses of E. coli and days after inoculation was examined. The analysis showed a significant difference in basal MBL levels of the 4 treatment groups at d 0. Visual inspection of the time series also indicated a general decline in MBL in the untreated group. Therefore, the MBL response was analyzed rather than the absolute MBL concentration. The response was calculated as (treatment value − d 0 value) for individual chickens, adjusted for the average decline from d 0 to 6 in the untreated controls.
The adjusted data were then analyzed using PROC MIXED in SAS (SAS Institute Inc., Cary, NC) with the following model:
where E i = effect of inoculated dose of E. coli and D j = effect of day after first inoculation. Chicken identity within treatment was used as a random factor to account for the fact that samples were repeated measures within chickens.
There was no significant difference in MBL between repeats, and because the dependent variable was adjusted response values, repeat was left out of the model. The MBL response values were not transformed because they were nearly normally distributed, and residuals vs. calculated values did not show a pattern indicating that transformation was needed.
Because there were no significant effects of day after first inoculation or interaction between day and dose, the model reduced to significant terms was:
Part 4. Analysis of IBDV antibody titers, E. coli antibody titers, daily weight gain, bursa:BW ratio, and data from T-cell stimulation was performed using PROC MIXED in SAS with the following model:
where Y ijkl = one of the above response variables for the lst chicken in the ith IBDV level, the jth E. coli level, and the kth MBL type; I i = effect of IBDV vaccination; E j = effect of E. coli inoculation; and M k = effect of MBL type.
Analysis of data for MBL serum concentration was performed using PROC MIXED in SAS with the following model
where I i = effect of IBDV vaccination; E j = effect of E. coli inoculation; M k = effect of MBL type; and D l = effect of day after first E. coli inoculation. Chicken identity within treatment was used as a random factor to account for the fact that samples were repeated measures within chickens.
RESULTS
Part 1
In the present study, MBL levels were measured in 2 flocks of ISA, LSL, LB, and HE, as shown in Figure   1A . 
Part 2
To test differences due to age, an ontogenetic study of the variation in serum MBL in a chicken line (L22) between 3 and 42 wk of age was performed ( Figure 1B) . The mean MBL level in this flock (n = 8) varied only slightly from 2 to 18 wk of age, with an increase at 5 to 7 wk of age. From wk 19, the serum MBL level showed a more constant increase that was maintained at least until 38 wk of age. There were no differences between serum MBL levels of female and male chickens.
Part 3
The acute phase response in chickens after nasal and oral inoculation with 3 different concentrations of E. coli was investigated to find the amount of E. coli necessary to provoke a measurable immune response. The experiment was repeated twice.
Lung tissues were tested 1, 2, and 3 d postinoculation as a control of colonization of E. coli. In lung cultures from mock-inoculated chickens, E. coli never appeared. On the other hand, E. coli appeared on all 3 test days in lung cultures from chickens of the 3 treatment groups, though not from all the chickens tested. At d 1, only a few colonies were seen in cultures of lung tissue from all 3 treatment groups. At d 2 and 3, the lowest number of colonies was seen in lungs from chickens inoculated with 10 6 cfu, and most colonies appeared in lungs from chickens inoculated with 10 8 and 10 10 cfu (results not shown). Selected colonies from tested lungs were all typed to be 1 of the 3 isotypes in the original inoculum. None of the chickens showed signs of diseases caused by E. coli infections.
The basal serum MBL level for each chicken was measured on d 0 before the first E. coli inoculation. There were no significant differences between the treatment groups (Figure 2) , and therefore, MBL statistics were calculated as an effect of treatment vs. control. A clear effect of inoculation with E. coli was seen, with significantly increased responses at d 2 (P = 0.0007) and d 4 (P = 0.0102) compared with the mock-inoculated group. The greatest level of MBL was seen at d 2 in the group inoculated with 10 8 cfu per chicken per day (P = 0.0057).
However, in this group, MBL levels declined with the fastest rate. At d 4, chickens receiving 10 6 and 10 10 cfu E. coli represented an increase over control values (10 6 cfu: P = 0.0581 and 10 10 cfu: P = 0.0630). The MBL levels in all E. coli-inoculated groups declined toward basal levels at d 6 (Figure 2) . The MBL was measured in serum from 20 randomly picked chickens at each time point from the flocks ISA 1, ISA 2, LSL 1, LSL 2, LB 1, and LB 2. In addition, measurements from 25 HE at 6 wk of age and from 22 HE of varying ages were obtained. Data are shown as mean MBL ± SE. B: Mean MBL values in 8 line 22 chickens followed from 3 wk of age until 42 wk of age. Data are given as mean MBL ± SE.
Part 4
At the age of 2 1/2 wk, chickens of high and low MBL type were placed in isolation chambers and subjected to either water or live attenuated IBDV vaccine at d 0. Subsequently, the chickens were subjected to either NaCl or E. coli inoculum at d 7 (Table 1) . Two repetitions of the experiment were run at the same time in separate isolation chambers.
The IBDV titers were measured at d 7 and 28 (results not shown). The IBDV antibody titers were positive only for chickens vaccinated with IBDV. The IBDV antibody titers were equally high at d 7 and 28.
Chickens were inoculated with E. coli on d 7, 8, and 9, and lung tissues were tested on d 7, 9, and 10 for the presence of E. coli. In cultures of lungs from chickens in the groups receiving no treatment (I−E−) or IBDV alone (I+E−) groups, E. coli never appeared. On the other hand, E. coli appeared in cultures of lungs from chickens in both the groups receiving E. coli alone (I−E+) and the groups receiving IBDV and E. coli (I+E+) on d 2 and 3 postinfection, although it did not appear in lung cultures from every chicken tested (results not shown).
To test the immune suppression, the bursa:BW ratio was determined in killed chickens at d 7, 9, 10, 11, and 14 ( Figure 3 ). The bursa:BW ratio was significantly reduced after vaccination with IBDV (P < 0.0001), whereas the subsequent inoculation with E. coli did not alter this ratio. The effect of IBDV vaccination on bursa:BW ratio was seen on d 10 to 14, and the ratio was independent of MBL type.
Body weight was measured in all blood-sampled chickens throughout the experiment. At d 0 of the experiment, there were no differences in BW between L-type and H-type chickens or between any of the experimental groups. The mean daily BW gain was calculated for each of the experimental groups (Figure 4) . The IBDV vaccine significantly lowered daily weight gain (P < 0.0001), and so did E. coli (P = 0.0024). In addition, it was found that, in the groups given E. coli, chickens of the MBL L-type had a significantly lower daily weight gain than chickens of the H-type (P = 0.0090).
Mean basal levels of serum MBL in chickens of the Htype and the L-type were 24.1 and 6.6 μg/mL, respectively, at d 7 (3 1/2 wk of age, Figure 5A and 5B). No increase in MBL was seen at d 3 to 4 in H-type chickens ( Figure 5A ). In the L-type chickens on the other hand, there was an increase in MBL in the group of chickens given both IBDV and E. coli compared with any of the other groups ( Figure 5B ), although this increase was nonsignificant.
Antibody titers to E. coli were measured in serum at d 28 (21 d after inoculation with E. coli, Figure 6 ). Development of antibodies against E. coli was significantly suppressed by IBDV vaccination (P = 0.0174). There were no interactions between IBDV vaccination and the E. coli challenge or the MBL type. Inoculation with experimental E. coli increased the antibody titers against E. coli, though not significantly, but only in the group of chickens that did not receive the IBDV vaccine. On d 28, T-cell stimulation was performed using peripheral blood mononuclear cells from chickens in the I−E− and the I+E+ groups of both the L-type and the H-type (5 chickens in each group of each type, Figure  7 ). After culture for 3 d in the presence of ConA (10 μg/mL for CD4 and 20 μg/mL for CD8), the percentage of proliferating CD4+ T cells from H-type chickens was significantly greater than those from the L-type chickens (P = 0.0410; Figure 7A ). The percentage of proliferating CD8+ T cells was also significantly greater in H-type chickens compared with L-type chickens (P = 0.0279, Figure 7B ). The increased percentage of proliferating CD8+ T cells in the H-type compared with the L-type chickens was more pronounced for chickens of the I−E− group than in chickens from the I+E+ group. However, there was no significant effect of treatment with IBDV and E. coli for chickens within an MBL type.
DISCUSSION
Part 1 and 2
The basal serum levels of MBL in chickens are known to vary from less than 1 to 35 μg/mL or more (Laursen and Nielsen, 2000) due to genetic variation. Results in this study also show large variation in basal serum MBL levels. Chickens of the HE line have basal MBL levels 2 to 3 times greater than the basal MBL levels in chickens from the other commercial chicken lines tested (Figure 1 ). Hellevad is generally believed to be a very robust breed due to the way it has been selected. Through 30 to 40 generations, the HE breed has not been vaccinated, and the breed has been selected for its high egg production in floor systems combined with characteristics that generally promote an appropriate behavior in a flock (Sørensen et al., 2004) .
Chickens in one of the HE groups were only 6 wk of age, and those in the other group were of mixed ages, whereas the 4 other breeds were tested during a time span of 16 to 39 wk. Within each flock, the serum MBL values were very homogeneous over time, even though the tested chickens were randomly picked in the flock at each time. On the other hand, the 2 LSL flocks differ largely. This could be due to the different ages these 2 flocks were tested at (3 to 16 wk of age vs. 17 to 55 wk of age).
To test this, we performed an ontogenetic study with chickens of an experimental line (L22). The results supported that age was a possible explanation for the difference between the 2 flocks, in that an increase in the mean MBL level was seen around 19 wk of age. This increase was maintained for several weeks and did not differ between males and females. This difference was not equally pronounced between the 2 LB flocks.
The data support that basal MBL levels are relatively constant within each of the age groups 9 to 18 wk of age and 19 to 38 wk of age but may be slightly increased at 5 to7 wk of age.
Part 3
This experiment was performed to find the amount of E. coli for inoculation of chickens to gain a measurable immune response. The HE breed was used for this experiment because of its robustness and high level of MBL.
Because only a few colonies were seen in cultures of lung tissue from chickens inoculated with 10 6 cfu E. coli, this seems to be a dose too small to colonize, and the lungs and the respiratory tract were actually cleared of bacteria too fast. Compared with that, the doses of 10 8 and 10 10 were large enough to pass the first barriers and colonize the lungs but not heavy enough to cause diseases.
In chickens, no reports on the MBL serum levels in response to E. coli inoculations have been published, but it is well known that human MBL has a strong ability to bind to various carbohydrate structures of bacteria and other pathogens, deposit complement factor 4 (C4) on the surface of microorganisms, and thereby be able to initiate the complement cascade (Neth et al., 2000; Norup and Juul-Madsen, 2007) . Mannose-binding lectin also has a very strong ability to bind to E. coli in humans (Shang et al., 2005) , and therefore, the MBL levels in chickens were expected to be affected by inoculation with E. coli.
The present findings are in agreement with the levels found after experimental inoculation with avian infectious bronchitis virus (Nielsen et al., 1999; Juul-Madsen et al., 2002 , 2003 , IBDV , and infectious laryngotracheitis virus (Nielsen et al., 1999) , which showed increased MBL levels at d 3 to 4 and a subsequent decline approaching normal levels at d 7. Although not all of these viruses contain binding sites for MBL, they initiate an acute phase response, which includes a systemic increase in MBL. In the present study, we only found an upregulation of approximately 30 to 40% after infection, which is lower than the 60 to 90% upregulation found by JuulMadsen et al. (2003) and the approximately 100% increase found by Laursen and Nielsen (2000) , in which chickens were exposed to viral infections. One reason for the relatively weak MBL response to inoculation could be that our chickens had high basal levels of MBL and therefore had no reason for a larger upregulation. An indication of this was found by Juul-Madsen et al. (2004) , in which 2 groups of chickens were infected with infectious bronchitis virus. One group had a low basal level of MBL (~4 μg/mL) and upregulated MBL by 130% after infection, whereas another group with a high basal level of MBL (~21 μg/mL) only upregulated MBL by 25 to 60%. Participation of other local immune mechanisms in the lungs could also reduce the systemic acute phase response. This is a mechanism observed by Shi et al. (2004) , who found that an i.v. injection with Staphylococcus aureus caused 100% mortality in MBL knockout mice compared with 45% in wild-type mice. In contrast, when injected in the peritoneal cavity, the mortality in both groups was reduced to 0%. Shi et al. (2004) found that a normal population of neutrophils combat the i.p. infection with S. aureus and therefore MBL was not needed.
In conclusion, the serum concentration of MBL was elevated at d 2 after inoculation with 10 6 to 10 10 cfu E. coli in HE chickens.
Part 4
Chickens from an experimental line selected for a high (H-line) or low (L-line) basal level of MBL for several generations were used for this experiment. The H-line and L-line had basal serum MBL levels of 24.1 and 6.6 μg/mL, respectively, which represent the highest and the lowest MBL values of the examined commercial chicken lines very well.
The IBDV titers and the bursa:BW ratio showed that the immunosuppression was successful and that there had been no contamination between the isolation chambers because only chickens in the groups given IBDV vaccine were seropositive.
Bursa to bodyweight ratio was significantly reduced 10 to 14 d after vaccination with IBDV ( Figure 3 ). This is a well-known effect of vaccination with most live IBDV vaccines (Bumstead et al., 1993; Tanimura et al., 1995; Hair-Bejo et al., 2004) . After infection with IBDV, or after vaccination with live attenuated IBDV vaccines, the bursa becomes edematous with a subsequent state of atrophy. It is clear that the bursa was in the state of atrophy in the period measured in this experiment. The bursa:BW ratio was not affected by E. coli infection.
Both vaccination with IBDV vaccine and infection with E. coli affected chicken BW gain negatively during the experimental period (Figure 4) . Growth retardation is common as a consequence of vaccination with the D78 IBDV vaccine, but the extent of retardation greatly depends on vaccination regimen in the flock (Paul et al., 2004) . Growth retardation in flocks infected with E. coli is also normal, depending on the severity of the infection. Ask et al. (2006b) found that increased susceptibility to infections with E. coli was associated with increased growth retardation. Ask et al. (2006a) also found a genotypic effect on growth retardation in broiler chickens due to infection with an E. coli O78 K80 strain. In the present study, an effect of MBL type was found in that the E. coli infection affected the growth in chickens of the L-type more severely than chickens of the H-type. Because chickens of the H-type and the Ltype had the same BW at the start of the experiment, the difference between MBL types in growth depression due to the E. coli cannot be attributed to differences in size and may thus be a direct consequence of basal levels of serum MBL.
In part 4, the measured MBL levels after inoculation with E. coli ( Figure 5A and B) showed large variation between chickens, and therefore, none of the effects on MBL levels in this experiment were significant. However, the largest increase in MBL serum concentration was seen in L-type chickens of the I+E+ group ( Figure  5B ), but the increase was not found to be significant, which is in contrast to the findings in experiment 1. For the H-type chickens, the absence of an acute phase response to E. coli measured by MBL was not very surprising because chickens with a high basal level of MBL may not need to or even be able to react with an elevated response to infections, as already mentioned.
Antibody titers to E. coli were depressed in the groups vaccinated with IBDV compared with the nonvaccinated groups, even in chickens not infected with experimental E. coli inoculum (Figure 6 ). All chickens are expected to develop antibodies against E. coli because it is a fecal bacterium that all individuals are in contact with continuously. Only those chickens that were not immune-suppressed responded to the experimental E. coli inoculation with increased antibody titers to E. coli. In the present experiment, chickens suppressed with IBDV clearly had their antibody production to E. coli abrogated at an early stage. Others have found similar observations on antibody development using Newcastle disease virus as challenging antigen (Giambrone, 1979; Muskett et al., 1979; Nakamura et al., 1992) .
From studies in humans, we know that E. coli is among the pathogens that MBL is known to bind to with an intermediate to strong affinity (Turner, 1996; Valdimarsson et al., 1998; Shi et al., 2004; Shang et al., 2005) , and because MBL is a potent opsonin and complement activator via the lectin pathway (Neth et al., 2000; Norup and Juul-Madsen, 2007) , H-type chickens were expected to clear their lungs from E. coli faster than L-type chickens, which could lead to a lower antibody response to E. coli in H-type chickens. However, in this experiment the E. coli antibody titers were not significantly affected by the basal serum MBL level.
Earlier investigations into the T-cell function after an IBDV infection or vaccination have revealed an impaired T-cell function in bursa, thymus, spleen, and peripheral blood, all depending on IBDV strain and strain virulence (Corley et al., 2001; Corley and Giambrone, 2002; Poonia and Charan, 2004; Williams and Davison, 2005) , age at infection (Giambrone et al., 1977; Sivanandan and Maheswaran, 1980) , and time after infection (Kim et al., 1998 Williams and Davison, 2005) . In the present study, T-cell function in peripheral blood lymphocytes was evaluated in H-type and L-type chickens at d 28 ( Figure 7) . No significant effect of IBDV vaccination and infection with E. coli on CD4+ and CD8+ T-cell proliferation potential was observed. This was not very surprising because other investigators conclude that impairment of peripheral blood lymphocyte function by IBDV is short and transient or even absent (Rodenberg et al., 1994; Poonia and Charan, 2004) . On the other hand, the subsequent infection with E. coli could have revealed some degree of interaction between treatment and MBL type. However, with respect with MBL type, it was found that T-cell proliferation in response to ConA was high in H-type chickens compared with L-type chickens for both CD4+ and CD8+ cells. Several investigations have established that chickens are dependent on T-cell function in controlling an IBDV infection Rautenschlein et al., 2002; Yeh et al., 2002; Williams and Davison, 2005) . In relation to this dependency, this experiment has shown that genetic selection against MBL may have changed T-cell function in one of the sublines, which is an issue for further investigation.
In conclusion, it has been found that the basal level of MBL seems to be important in protecting chickens against E. coli infections due to lower BW gain in E. coli-infected chickens with low MBL. Therefore, MBL may be a future selection parameter in choosing chickens for outdoor or organic farming. It was also shown that the basal level of MBL seems to be of importance for specific immune responses. However, further investigations concerning the level of MBL and the possible effect on responses to vaccines and vaccination programs commonly used in poultry production have to be performed. 
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